Sartorius Stedim Biotech S.A. (ADR)

Factors to consider:

• Company pays dividends (annually): last record date 2026-04-01, amount 0.08$ (Y0.44%)
• Price in estimated range

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

• 2025-12-31 to 2026-12-31 estimated range: [15.19$, 28.18$]
• 2026-12-31 to 2027-12-31 estimated range: [15.02$, 27.85$]

Financial Metrics affecting the SRTOY estimates:

• Positive: with PPE of 125.5 at the end of fiscal year the price was neutral
• Positive: 7.68 < Operating profit margin, % of 18.50
• Positive: 1.88 < Return on assets ratio (scaled to [-100,100]) of 3.09
• Negative: Industry operating profit margin (median), % of -1.25 <= 3.02
• Negative: Industry operating cash flow per share per price (median), % of 2.91 <= 5.46
• Negative: Industry earnings per price (median), % of 0 <= 0
• Positive: Investing cash flow per share per price, % of -0.19 > -0.65
• Positive: 0.07 < Operating cash flow per share per price, % of 0.26
• Positive: 42.60 < Shareholder equity ratio, % of 51.02 <= 64.25